Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli

Antimicrobial-resistant bacteria represent a major threat to human and animal health. We compared equine fecal samples ( n =264) from 138 horses from hospital and nonhospital (livery stable and riding school) premises in North West England to determine the prevalence of Escherichia coli , Salmonella...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2012-04, Vol.18 (2), p.161-168
Hauptverfasser: Ahmed, Mohamed O., Williams, Nicola J., Clegg, Peter D., van Velkinburgh, Jennifer C., Baptiste, Keith E., Bennett, Malcolm
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 168
container_issue 2
container_start_page 161
container_title Microbial drug resistance (Larchmont, N.Y.)
container_volume 18
creator Ahmed, Mohamed O.
Williams, Nicola J.
Clegg, Peter D.
van Velkinburgh, Jennifer C.
Baptiste, Keith E.
Bennett, Malcolm
description Antimicrobial-resistant bacteria represent a major threat to human and animal health. We compared equine fecal samples ( n =264) from 138 horses from hospital and nonhospital (livery stable and riding school) premises in North West England to determine the prevalence of Escherichia coli , Salmonella , and Campylobacter and rates of antimicrobial-resistant E. coli strains. Campylobacter jejuni was detected only in hospitalized horses (1.1%), and no Salmonella was identified. Data analysis of the horses' management and veterinary treatments (Tx) identified risk factors associated with shedding of antimicrobial-resistant E. coli . The hospital was the major source of resistant and multi-drug-resistant (MDR) E. coli . Moreover, shedding of antimicrobial-resistant E. coli was associated significantly with hospitalization for a gastrointestinal problem (odds ratio [OR]:±95% confidence intervals=8.50:1.79–40.32), receipt of oral antimicrobial Tx (OR=3.52:1.11–11.10), multiple antimicrobial Tx in hospital (OR/Tx=1.05:1.01–1.09), or geldings (OR=4.62:1.23–17.46). Interestingly, intravenous antimicrobial Tx was negatively associated with shedding of antimicrobial-resistant E. coli (OR=0.18:0.04–0.76). MDR E. coli was associated with hospitalization, antimicrobial Tx in hospital (OR/Tx=3.65:1.54–8.68), and increased age (OR/year=1.11:1.03–1.19). Thus, equine hospitals in this geographic location appear to be an important source of antimicrobial-resistant and MDR E. coli strains, but unlikely reservoirs of Salmonella or Campylobacter . Thus, it is important to moderate antimicrobial Tx given to hospitalized horses to lessen exposure and fecal shedding of resistant pathogens.
doi_str_mv 10.1089/mdr.2011.0213
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_993315570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>993315570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-4b03c78497ae569ffc3684bb10f9d836c2c64c081cee87fb8876858af1104fb23</originalsourceid><addsrcrecordid>eNqFkUFPwyAYhonRuDk9ejWNF710QqEUjsuyqYnRZNFzQylkzLZMoDH799JsevCgXD7y5fnew_sAcIngFEHG79raTTOI0BRmCB-BMeIYpYwQdhz_sKApzTgZgTPvNxDCHFF8CkZZfJwhNgbPs040O298YnWyMv49WQoZrPPJzHsrjQiqTj5NWCezLpjK2GBkulLxIIguJAsv18oZuTYikbYx5-BEi8ari8OcgLfl4nX-kD693D_OZ0-pxJyGlFQQy4IRXgiVU661xJSRqkJQ85phKjNJiYQMSaVYoSvGCspyJjRCkOgqwxNws8_dOvvRKx_K1nipmkZ0yva-5BxjlOcFjOTtnySK3cXmckIjev0L3djexX6GvIxRnrMiQukeks5675Qut860wu1iUjkYKaORcjBSDkYif3UI7atW1T_0t4II4D0wrEXXNUZVyoV_Yr8ArvSWjA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>992869587</pqid></control><display><type>article</type><title>Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Ahmed, Mohamed O. ; Williams, Nicola J. ; Clegg, Peter D. ; van Velkinburgh, Jennifer C. ; Baptiste, Keith E. ; Bennett, Malcolm</creator><creatorcontrib>Ahmed, Mohamed O. ; Williams, Nicola J. ; Clegg, Peter D. ; van Velkinburgh, Jennifer C. ; Baptiste, Keith E. ; Bennett, Malcolm</creatorcontrib><description>Antimicrobial-resistant bacteria represent a major threat to human and animal health. We compared equine fecal samples ( n =264) from 138 horses from hospital and nonhospital (livery stable and riding school) premises in North West England to determine the prevalence of Escherichia coli , Salmonella , and Campylobacter and rates of antimicrobial-resistant E. coli strains. Campylobacter jejuni was detected only in hospitalized horses (1.1%), and no Salmonella was identified. Data analysis of the horses' management and veterinary treatments (Tx) identified risk factors associated with shedding of antimicrobial-resistant E. coli . The hospital was the major source of resistant and multi-drug-resistant (MDR) E. coli . Moreover, shedding of antimicrobial-resistant E. coli was associated significantly with hospitalization for a gastrointestinal problem (odds ratio [OR]:±95% confidence intervals=8.50:1.79–40.32), receipt of oral antimicrobial Tx (OR=3.52:1.11–11.10), multiple antimicrobial Tx in hospital (OR/Tx=1.05:1.01–1.09), or geldings (OR=4.62:1.23–17.46). Interestingly, intravenous antimicrobial Tx was negatively associated with shedding of antimicrobial-resistant E. coli (OR=0.18:0.04–0.76). MDR E. coli was associated with hospitalization, antimicrobial Tx in hospital (OR/Tx=3.65:1.54–8.68), and increased age (OR/year=1.11:1.03–1.19). Thus, equine hospitals in this geographic location appear to be an important source of antimicrobial-resistant and MDR E. coli strains, but unlikely reservoirs of Salmonella or Campylobacter . Thus, it is important to moderate antimicrobial Tx given to hospitalized horses to lessen exposure and fecal shedding of resistant pathogens.</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/mdr.2011.0213</identifier><identifier>PMID: 22229818</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Age ; Animals ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotic resistance ; Antimicrobial agents ; Campylobacter - drug effects ; Campylobacter - isolation &amp; purification ; Campylobacter jejuni ; Child ; Colony Count, Microbial ; Data processing ; Drug resistance ; Drug Resistance, Multiple, Bacterial ; E coli ; Epidemiology ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - isolation &amp; purification ; Fecal coliforms ; Feces - microbiology ; Female ; Horses ; Horses - microbiology ; Hospitals ; Hospitals, Animal - statistics &amp; numerical data ; Humans ; Intravenous administration ; Male ; Microbial Sensitivity Tests ; Pathogens ; Prevalence ; Public health ; Reservoirs ; Risk analysis ; Risk Factors ; Salmonella ; Salmonella - drug effects ; Salmonella - isolation &amp; purification ; schools</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 2012-04, Vol.18 (2), p.161-168</ispartof><rights>2012, Mary Ann Liebert, Inc.</rights><rights>(©) Copyright 2012, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-4b03c78497ae569ffc3684bb10f9d836c2c64c081cee87fb8876858af1104fb23</citedby><cites>FETCH-LOGICAL-c396t-4b03c78497ae569ffc3684bb10f9d836c2c64c081cee87fb8876858af1104fb23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22229818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Mohamed O.</creatorcontrib><creatorcontrib>Williams, Nicola J.</creatorcontrib><creatorcontrib>Clegg, Peter D.</creatorcontrib><creatorcontrib>van Velkinburgh, Jennifer C.</creatorcontrib><creatorcontrib>Baptiste, Keith E.</creatorcontrib><creatorcontrib>Bennett, Malcolm</creatorcontrib><title>Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>Antimicrobial-resistant bacteria represent a major threat to human and animal health. We compared equine fecal samples ( n =264) from 138 horses from hospital and nonhospital (livery stable and riding school) premises in North West England to determine the prevalence of Escherichia coli , Salmonella , and Campylobacter and rates of antimicrobial-resistant E. coli strains. Campylobacter jejuni was detected only in hospitalized horses (1.1%), and no Salmonella was identified. Data analysis of the horses' management and veterinary treatments (Tx) identified risk factors associated with shedding of antimicrobial-resistant E. coli . The hospital was the major source of resistant and multi-drug-resistant (MDR) E. coli . Moreover, shedding of antimicrobial-resistant E. coli was associated significantly with hospitalization for a gastrointestinal problem (odds ratio [OR]:±95% confidence intervals=8.50:1.79–40.32), receipt of oral antimicrobial Tx (OR=3.52:1.11–11.10), multiple antimicrobial Tx in hospital (OR/Tx=1.05:1.01–1.09), or geldings (OR=4.62:1.23–17.46). Interestingly, intravenous antimicrobial Tx was negatively associated with shedding of antimicrobial-resistant E. coli (OR=0.18:0.04–0.76). MDR E. coli was associated with hospitalization, antimicrobial Tx in hospital (OR/Tx=3.65:1.54–8.68), and increased age (OR/year=1.11:1.03–1.19). Thus, equine hospitals in this geographic location appear to be an important source of antimicrobial-resistant and MDR E. coli strains, but unlikely reservoirs of Salmonella or Campylobacter . Thus, it is important to moderate antimicrobial Tx given to hospitalized horses to lessen exposure and fecal shedding of resistant pathogens.</description><subject>Age</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic resistance</subject><subject>Antimicrobial agents</subject><subject>Campylobacter - drug effects</subject><subject>Campylobacter - isolation &amp; purification</subject><subject>Campylobacter jejuni</subject><subject>Child</subject><subject>Colony Count, Microbial</subject><subject>Data processing</subject><subject>Drug resistance</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>E coli</subject><subject>Epidemiology</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - isolation &amp; purification</subject><subject>Fecal coliforms</subject><subject>Feces - microbiology</subject><subject>Female</subject><subject>Horses</subject><subject>Horses - microbiology</subject><subject>Hospitals</subject><subject>Hospitals, Animal - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Intravenous administration</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Pathogens</subject><subject>Prevalence</subject><subject>Public health</subject><subject>Reservoirs</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Salmonella</subject><subject>Salmonella - drug effects</subject><subject>Salmonella - isolation &amp; purification</subject><subject>schools</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkUFPwyAYhonRuDk9ejWNF710QqEUjsuyqYnRZNFzQylkzLZMoDH799JsevCgXD7y5fnew_sAcIngFEHG79raTTOI0BRmCB-BMeIYpYwQdhz_sKApzTgZgTPvNxDCHFF8CkZZfJwhNgbPs040O298YnWyMv49WQoZrPPJzHsrjQiqTj5NWCezLpjK2GBkulLxIIguJAsv18oZuTYikbYx5-BEi8ari8OcgLfl4nX-kD693D_OZ0-pxJyGlFQQy4IRXgiVU661xJSRqkJQ85phKjNJiYQMSaVYoSvGCspyJjRCkOgqwxNws8_dOvvRKx_K1nipmkZ0yva-5BxjlOcFjOTtnySK3cXmckIjev0L3djexX6GvIxRnrMiQukeks5675Qut860wu1iUjkYKaORcjBSDkYif3UI7atW1T_0t4II4D0wrEXXNUZVyoV_Yr8ArvSWjA</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Ahmed, Mohamed O.</creator><creator>Williams, Nicola J.</creator><creator>Clegg, Peter D.</creator><creator>van Velkinburgh, Jennifer C.</creator><creator>Baptiste, Keith E.</creator><creator>Bennett, Malcolm</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7U1</scope><scope>7U2</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli</title><author>Ahmed, Mohamed O. ; Williams, Nicola J. ; Clegg, Peter D. ; van Velkinburgh, Jennifer C. ; Baptiste, Keith E. ; Bennett, Malcolm</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-4b03c78497ae569ffc3684bb10f9d836c2c64c081cee87fb8876858af1104fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Age</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic resistance</topic><topic>Antimicrobial agents</topic><topic>Campylobacter - drug effects</topic><topic>Campylobacter - isolation &amp; purification</topic><topic>Campylobacter jejuni</topic><topic>Child</topic><topic>Colony Count, Microbial</topic><topic>Data processing</topic><topic>Drug resistance</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>E coli</topic><topic>Epidemiology</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - isolation &amp; purification</topic><topic>Fecal coliforms</topic><topic>Feces - microbiology</topic><topic>Female</topic><topic>Horses</topic><topic>Horses - microbiology</topic><topic>Hospitals</topic><topic>Hospitals, Animal - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Intravenous administration</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Pathogens</topic><topic>Prevalence</topic><topic>Public health</topic><topic>Reservoirs</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Salmonella</topic><topic>Salmonella - drug effects</topic><topic>Salmonella - isolation &amp; purification</topic><topic>schools</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Mohamed O.</creatorcontrib><creatorcontrib>Williams, Nicola J.</creatorcontrib><creatorcontrib>Clegg, Peter D.</creatorcontrib><creatorcontrib>van Velkinburgh, Jennifer C.</creatorcontrib><creatorcontrib>Baptiste, Keith E.</creatorcontrib><creatorcontrib>Bennett, Malcolm</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Mohamed O.</au><au>Williams, Nicola J.</au><au>Clegg, Peter D.</au><au>van Velkinburgh, Jennifer C.</au><au>Baptiste, Keith E.</au><au>Bennett, Malcolm</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>18</volume><issue>2</issue><spage>161</spage><epage>168</epage><pages>161-168</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>Antimicrobial-resistant bacteria represent a major threat to human and animal health. We compared equine fecal samples ( n =264) from 138 horses from hospital and nonhospital (livery stable and riding school) premises in North West England to determine the prevalence of Escherichia coli , Salmonella , and Campylobacter and rates of antimicrobial-resistant E. coli strains. Campylobacter jejuni was detected only in hospitalized horses (1.1%), and no Salmonella was identified. Data analysis of the horses' management and veterinary treatments (Tx) identified risk factors associated with shedding of antimicrobial-resistant E. coli . The hospital was the major source of resistant and multi-drug-resistant (MDR) E. coli . Moreover, shedding of antimicrobial-resistant E. coli was associated significantly with hospitalization for a gastrointestinal problem (odds ratio [OR]:±95% confidence intervals=8.50:1.79–40.32), receipt of oral antimicrobial Tx (OR=3.52:1.11–11.10), multiple antimicrobial Tx in hospital (OR/Tx=1.05:1.01–1.09), or geldings (OR=4.62:1.23–17.46). Interestingly, intravenous antimicrobial Tx was negatively associated with shedding of antimicrobial-resistant E. coli (OR=0.18:0.04–0.76). MDR E. coli was associated with hospitalization, antimicrobial Tx in hospital (OR/Tx=3.65:1.54–8.68), and increased age (OR/year=1.11:1.03–1.19). Thus, equine hospitals in this geographic location appear to be an important source of antimicrobial-resistant and MDR E. coli strains, but unlikely reservoirs of Salmonella or Campylobacter . Thus, it is important to moderate antimicrobial Tx given to hospitalized horses to lessen exposure and fecal shedding of resistant pathogens.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>22229818</pmid><doi>10.1089/mdr.2011.0213</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-6294
ispartof Microbial drug resistance (Larchmont, N.Y.), 2012-04, Vol.18 (2), p.161-168
issn 1076-6294
1931-8448
language eng
recordid cdi_proquest_miscellaneous_993315570
source MEDLINE; Alma/SFX Local Collection
subjects Age
Animals
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibiotic resistance
Antimicrobial agents
Campylobacter - drug effects
Campylobacter - isolation & purification
Campylobacter jejuni
Child
Colony Count, Microbial
Data processing
Drug resistance
Drug Resistance, Multiple, Bacterial
E coli
Epidemiology
Escherichia coli
Escherichia coli - drug effects
Escherichia coli - isolation & purification
Fecal coliforms
Feces - microbiology
Female
Horses
Horses - microbiology
Hospitals
Hospitals, Animal - statistics & numerical data
Humans
Intravenous administration
Male
Microbial Sensitivity Tests
Pathogens
Prevalence
Public health
Reservoirs
Risk analysis
Risk Factors
Salmonella
Salmonella - drug effects
Salmonella - isolation & purification
schools
title Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T12%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20Risk%20Factors%20Associated%20with%20Antibiotic-Resistant%20Escherichia%20coli&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Ahmed,%20Mohamed%20O.&rft.date=2012-04-01&rft.volume=18&rft.issue=2&rft.spage=161&rft.epage=168&rft.pages=161-168&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/mdr.2011.0213&rft_dat=%3Cproquest_cross%3E993315570%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=992869587&rft_id=info:pmid/22229818&rfr_iscdi=true